2012
Yanagawa B, Lovren F, Pan Y, Garg V, Quan
A, Tang G, Singh KK, Shukla PC, Kalra NP, Peterson MD, Verma S.
miRNA-141 is a novel regulator of
BMP-2-mediated calcification in aortic stenosis.
J Thorac Cardiovasc Surg. 2012 Feb 13.
(in press)
Gupta M, Singh N, Tsigoulis M, Kajil M,
Hirjikaka S, Quan A, Teoh H, Verma S.
Perceptions of Canadian primary care
physicians towards cardiovascular risk assessment and lipid management.
Can J Cardiol. 2012 Jan-Feb;28(1):14-9.
Teoh H, Quan A, Creighton AK, Annie Bang
KW, Singh KK, Shukla PC, Gupta N, Pan Y, Lovren F, Leong-Poi H, Al-Omran
M, Verma S.
BRCA1 gene therapy reduces systemic
inflammatory response and multiple organ failure and improves survival
in experimental sepsis.
Gene Ther. 2012 Jan 19. (in press)
Singh KK, Shukla PC, Quan A, Desjardins
JF, Lovren F, Pan Y, Garg V, Gosal S, Garg A, Szmitko PE, Schneider MD,
Parker TG, Stanford WL, Leong-Poi H, Teoh H, Al-Omran M, Verma S.
BRCA2 Protein Deficiency Exaggerates
Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure.
J Biol Chem. 2012 Feb 24;287(9):6604-14.
2011
Shukla PC, Singh KK, Quan A, Al-Omran M,
Teoh H, Lovren F, Cao L, Rovira II, Pan Y, Brezden-Masley C, Yanagawa B,
Gupta A, Deng CX, Coles JG, Leong-Poi H, Stanford WL, Parker TG,
Schneider MD, Finkel T, Verma S.
BRCA1 is an essential regulator of heart
function and survival following myocardial infarction.
Nat Commun. 2011 Dec 20;2:593.
Al-Omran M, Verma S, Lindsay TF.
Suboptimal use of risk reduction therapy in
peripheral arterial disease patients at a major teaching hospital.
Ann Saudi Med. 2011 Jul-Aug;31(4):371-5.
Singh KK, Shukla PC, Quan A, Lovren F, Pan
Y, Wolfstadt JI, Gupta M, Al-Omran M, Leong-Poi H, Teoh H, Verma S.
Herceptin, a recombinant humanized anti-ERBB2
monoclonal antibody, induces cardiomyocyte death.
Biochem Biophys Res Commun. 2011 Jul
29;411(2):421-6.
Effects on duration of post-operative
ischemia and patterns of blood flow recovery in different conditions of
mouse hind limb ischemia.
Vasc Cell. 2011 Jun 14;3(1):14.
Cardiometabolic Risk Working Group:
Executive Committee, Leiter LA, Fitchett DH, Gilbert RE, Gupta M,
Mancini GB, McFarlane PA, Ross R, Teoh H, Verma S, Anand S, Camelon K,
Chow CM, Cox JL, Després JP, Genest J, Harris SB, Lau DC, Lewanczuk R,
Liu PP, Lonn EM, McPherson R, Poirier P, Qaadri S, Rabasa-Lhoret R,
Rabkin SW, Sharma AM, Steele AW, Stone JA, Tardif JC, Tobe S, Ur E.
Identification and management of
cardiometabolic risk in
Can J Cardiol. 2011 Mar-Apr;27(2):124-31.
Verma S, Gupta M, Holmes DT, Xu L, Teoh H,
Gupta S, Yusuf S, Lonn EM.
Plasma renin activity predicts cardiovascular
mortality in the Heart Outcomes Prevention Evaluation (HOPE) study.
Eur Heart J. 2011 Sep;32(17):2135-42.
Anderson TJ, Charbonneau F, Title LM,
Buithieu J, Rose MS, Conradson H, Hildebrand K, Fung M, Verma S, Lonn
EM.
Microvascular function predicts
cardiovascular events in primary prevention: long-term results from the
Firefighters and Their Endothelium (FATE) study.
Circulation. 2011 Jan 18;123(2):163-9.
Lovren F, Pan Y, Quan A, Singh KK, Shukla
PC, Gupta M, Al-Omran M, Teoh H, Verma S.
Adropin is a novel regulator of endothelial
function.
Circulation. 2010 Sep 14;122(11 Suppl):S185-92.
Lovren F, Pan Y, Quan A, Szmitko PE, Singh
KK, Shukla PC, Gupta M, Chan L, Al-Omran M, Teoh H, Verma S.
Adiponectin primes human monocytes into
alternative anti-inflammatory M2 macrophages.
Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H656-63.
Gupta M, Szmitko PE, Tsigoulis M, Braga
MF, Kajil M, Herjikaka S, Quan A, Teoh H, Verma S.
Effects of ezetimibe add-on to statin therapy
on adipokine production in patients with metabolic syndrome and stable
vascular disease.
J Cardiovasc Pharmacol. 2010
Sep;56(3):241-5.
Shukla PC, Singh KK, Yanagawa B, Teoh H,
Verma S.
Can J Cardiol. 2010 Mar;26 Suppl
A:13A-16A.
2010
Shukla PC, Singh KK, Yanagawa B, Teoh H,
Verma S
DNA Damage Repair and Cardiovascular
Diseases.
Can J Cardiol. (in press)
Szmitko PE, Leiter LA, Verma S
The incretin system and cardiometabolic
disease.
Can J Cardiol 2010: 26: 87-95.
2009
Verma S, Mesana TG
Mitral-valve repair for mitral-valve
prolapse.
N Engl J Med 2009: 361: pp 2261-9.
Fitchett D, Eikelboom J, Fremes A, Mazer
S, Singh A, Bittira B, Brister A, Graham JJ, Gupta M, Karkouti K, Lee A,
Love M, McArthur R, Peterson M, Verma S, Yau, TM
Dual antiplatelet therapy in patients
requiring urgent coronary artery bypass grafting surgery: A position
statement of the Canadian Cardiovascular Society.
Can J Cardiol: 2009: 25(12): pp 683-9.
MV Badiwala,
Surgical Management of Ischemic Mitral
Regurgitation.
Circulation: 2009: 120(13): pp 1287-93.
Philpott AC, Lonn E, Title LM, Verma S,
Buithieu J, Charbonneau F, Anderson TJ.
Comparison of new measures of vascular
function to flow mediated dilatation as a measure of cardiovascular risk
factors.
Am J Cardiol. 2009 Jun 1;103(11):1610-5..
Nocturnal haemodialysis is associated with
improved vascular smooth muscle cell biology.
Nephrol Dial Transplant. 2009: 24(12): pp
3867-71.
Yan RT, Yan AT,
The differential association between various
anthropometric indices of obesity and subclinical atherosclerosis.
Atherosclerosis. 2009 Apr 16. [Epub ahead
of print]
Kuo LT, Chen SJ, Cherng WJ, Yang NI, Lee
CC, Cheng CW, Verma S, Wang CH.
Late reperfusion of a totally occluded
infarct-related artery increases granulocyte-colony stimulation factor
and reduces stroma-derived factor-1alpha blood levels in patients with
ongoing ischemia after acute myocardial infarction.
Int Heart J. 2009 Jul;50(4):433-44.
Verma S, Lonn EM, Nanji A, Browne K, Ward
R, Robertson A, Conradson H, Hildebrand K, Brant R, Anderson TJ.
Effect of angiotensin-converting enzyme
inhibition on C-reactive protein levels: the ramipril C-reactive pRotein
randomized evaluation (4R) trial results.
Can J Cardiol. 2009 Jul;25(7):e236-40.
Gupta M,
Statin effects on LDL and HDL cholesterol in
South Asian and white populations.
J Clin Pharmacol. 2009 Jul;49(7):831-7.
Lovren F, Pan Y, Shukla PC, Quan A, Teoh
H, Szmitko PE, Peterson MD, Gupta M, Al-Omran M, Verma S.
Visfatin activates eNOS via Akt and MAP
kinases and improves endothelial cell function and angiogenesis in vitro
and in vivo: translational implications for atherosclerosis.
Am J Physiol Endocrinol Metab. 2009
Jun;296(6):E1440-9.
Desjardins JF, Pourdjabbar A, Quan A,
Leong-Poi H, Teichert-Kuliszewska K, Verma S, Parker TG.
Lack of S100A1 in mice confers a
gender-dependent hypertensive phenotype and increased mortality after
myocardial infarction.
Am J Physiol Heart Circ Physiol. 2009
May;296(5):H1457-65.
Jialal I, Verma S, Devaraj S.
Inhibition of endothelial nitric oxide
synthase by C-reactive protein: clinical relevance.
Clin Chem. 2009 Feb;55(2):206-8.
2008
Title LM, Lonn E, Charbonneau F, Fung M,
Mather KJ, Verma S, Anderson TJ.
Relationship between brachial artery
flow-mediated dilatation, hyperemic shear stress, and the metabolic
syndrome.
Vasc Med. 2008 Nov;13(4):263-70.
Gupta M,
A randomized, controlled trial of the effects
of rosiglitazone on adipokines, and inflammatory and fibrinolytic
markers in diabetic patients: study design and protocol.
Can J Cardiol. 2008 Oct;24(10):e65-9.
Kuo LT, Yang NI, Cherng WJ, Verma S, Hung
MJ, Wang SY, Liu MH, Chen SY, Wang CH.
Serum interleukin-6 levels, not genotype,
correlate with coronary plaque complexity.
Int Heart J. 2008 Jul;49(4):391-402.
Lovren F, Pan Y, Quan A, Teoh H, Wang G,
Shukla PC, Levitt KS, Oudit GY, Al-Omran M, Stewart DJ, Slutsky AS,
Peterson MD, Backx PH, Penninger JM, Verma S.
Angiotensin converting enzyme-2 confers
endothelial protection and attenuates atherosclerosis.
Am J Physiol Heart Circ Physiol. 2008
Oct;295(4):H1377-84.
Verma S, Gupta MK.
Aliskiren improves nitric oxide
bioavailability and limits atherosclerosis.
Hypertension. 2008 Sep;52(3):467-9.
Teoh H, Quan A, Bang KW, Wang G, Lovren F,
Vu V, Haitsma JJ, Szmitko PE, Al-Omran M, Wang CH, Gupta M, Peterson MD,
Zhang H, Chan L, Freedman J, Sweeney G, Verma S.
Adiponectin deficiency promotes endothelial
activation and profoundly exacerbates sepsis-related mortality.
Am J Physiol Endocrinol Metab. 2008
Sep;295(3):E658-64.
Al-Omran M, Mamdani MM, Lindsay TF, Melo
M, Juurlink DN, Verma S; Systematic Assessment of Vascular Risk
Investigators.
Suboptimal use of statin therapy in elderly
patients with atherosclerosis: a population-based study.
J Vasc Surg. 2008 Sep;48(3):607-12.
The endocannabinoid system and
cardiometabolic risk.
Atherosclerosis. 2008 Aug;199(2):248-56.
Teoh H, Quan A, Lovren F, Wang G, Tirgari
S, Szmitko PE, Szalai AJ, Ward ME, Verma S.
Impaired endothelial function in C-reactive
protein overexpressing mice.
Atherosclerosis. 2008 Dec;201(2):318-25.
Kim BO, Verma S, Weisel RD, Fazel S, Jia
ZQ, Mizuno T, Li RK.
Preservation of heart function in diabetic
rats by the combined effects of muscle cell implantation and insulin
therapy.
Eur J Heart Fail. 2008 Jan;10(1):14-21.
Wang CH, Cherng WJ, Yang NI, Hsu CM, Yeh
CH, Lan YJ, Wang JS, Verma S.
Cyclosporine increases ischemia-induced
endothelial progenitor cell mobilization through manipulation of the
CD26 system.
Am J Physiol Regul Integr Comp Physiol.
2008 Mar;294(3):R811-8.
2007
Teoh H, Verma S.
C-reactive protein, metabolic syndrome, and
end organ damage.
Metabolism. 2007 Dec;56(12):1620-2.
Gupta M, Verma S, Mancini GB.
ACE inhibitors: back to prime time?
Heart. 2007 Sep;93(9):1015-6.
Teoh H, Quan A, Verma S.
Does C-reactive protein predict saphenous
vein graft patency?
J Thorac Cardiovasc Surg. 2007
Aug;134(2):277-9.
C-reactive protein and reendothelialization:
NO involvement.
Circ Res. 2007 May 25;100(10):1405-7.
Verma S,
Idiopathic pulmonary fibrosis--new insights.
N Engl J Med. 2007 Mar 29;356(13):1370-2.
Teoh H, Lovren F, Verma S.
Vascular dysfunction: a Janus face of
visfatin in diabetes?
Metabolism. 2007 Apr;56(4):459-61.
Verma S, Feindel CM.
Skeletonized internal thoracic arteries for
CABG surgery: a new gold standard?
Nat Clin Pract Cardiovasc Med. 2007
Apr;4(4):188-9.
Adiponectin and cardiovascular disease: state
of the art?
Am J Physiol Heart Circ Physiol. 2007
Apr;292(4):H1655-63. Review.
Wang CH, Verma S, Hsieh IC, Hung A, Cheng
TT, Wang SY, Liu YC, Stanford WL, Weisel RD, Li RK, Cherng WJ.
Stem cell factor attenuates vascular smooth
muscle apoptosis and increases intimal hyperplasia after vascular
injury.
Arterioscler Thromb Vasc Biol. 2007
Mar;27(3):540-7.
Brister SJ, Hamdulay Z, Verma S, Maganti
M, Buchanan MR.
Ethnic diversity: South Asian ethnicity is
associated with increased coronary artery bypass grafting mortality.
J Thorac Cardiovasc Surg. 2007
Jan;133(1):150-4.